<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Mutations in KCNJ2, the gene encoding the human inward rectifier <z:chebi fb="120" ids="26216">potassium</z:chebi> channel Kir2.1 (IK1 or IKir2.1), have been identified in <z:e sem="disease" ids="C1563715" disease_type="Disease or Syndrome" abbrv="">Andersen-Tawil syndrome</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C1563715" disease_type="Disease or Syndrome" abbrv="">Andersen-Tawil syndrome</z:e> is a multisystem <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">inherited disease</z:e> exhibiting <z:hpo ids='HP_0003768'>periodic paralysis</z:hpo>, <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo>, and dysmorphic features at times mimicking catecholaminergic polymorphic <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: Our proband displayed dysmorphic features including <z:hpo ids='HP_0000347'>micrognathia</z:hpo>, <z:mp ids='MP_0006253'>clinodactyly</z:mp>, and <z:hpo ids='HP_0001159'>syndactyly</z:hpo> and exhibited multiform <z:mp ids='MP_0009732'>extrasystoles</z:mp> and bidirectional <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> both at rest and during exercise testing </plain></SENT>
<SENT sid="3" pm="."><plain>The patient's symptoms continued after administration of <z:chebi fb="0" ids="7444">nadolol</z:chebi> but subsided after treatment with flecainide </plain></SENT>
<SENT sid="4" pm="."><plain>Molecular genetic screening revealed a novel heterozygous mutation (c.779G&gt;C/p.R260P) in KCNJ2 </plain></SENT>
<SENT sid="5" pm="."><plain>Whole-cell patch-clamp studies conducted in TSA201 cells transfected with <z:mp ids='MP_0002169'>wild-type</z:mp> human KCNJ2 cDNA (WT-KCNJ2) yielded robust IKir2.1 but no measurable current in cells expressing the R260P mutant </plain></SENT>
<SENT sid="6" pm="."><plain>Coexpression of WT and R260P-KCNJ2 (heterozygous expression) yielded a markedly reduced inward IKir2.1 compared with WT alone (-36.5±9.8 pA/pF versus -143.5±11.4 pA/pF, n=8 for both, P&lt;0.001, respectively, at -90 mV), indicating a strong dominant negative effect of the mutant </plain></SENT>
<SENT sid="7" pm="."><plain>The outward component of IKir2.1 measured at -50 mV was also markedly reduced with the heterozygous expression versus WT (0.52±5.5 pA/pF versus 23.4±6.7 pA/pF, n=8 for both, P&lt;0.001, respectively) </plain></SENT>
<SENT sid="8" pm="."><plain>Immunocytochemical analysis indicates that impaired trafficking of R260P-KCNJ2 channels </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: We report a novel de novo KCNJ2 mutation associated with classic phenotypic features of <z:e sem="disease" ids="C1563715" disease_type="Disease or Syndrome" abbrv="">Andersen-Tawil syndrome</z:e> and catecholaminergic polymorphic <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> mimicry </plain></SENT>
<SENT sid="10" pm="."><plain>The R260P mutation produces a strong dominant negative effect leading to marked suppression of IK1 secondary to a trafficking defect </plain></SENT>
</text></document>